Wells Fargo agrees to pay $105M to end MedCap suit

Investor recovery pool for failed private placements balloons by $105 million. Bruce Kelly has the details.
AUG 08, 2013
The pot of restoration money for investors in the Medical Capital Holdings Ponzi scheme got a little heftier Tuesday. Wells Fargo & Co., one of two trustee banks for the scheme, agreed to pay $105 million to a class of note holders who alleged that they suffered damages because the bank failed to protect their interests. In February, Bank of New York Mellon Corp., the other trustee bank, agreed to pay $114 million to settle similar claims. Dozens of independent broker-dealers sold Medical Capital notes from 2003 to 2009, raising about $2.2 billion for the fraudulent medical receivables scheme. The private placement was a high-commission product that promised interest-rate returns of 8.5% to 10.5%. The Securities and Exchange Commission sued MedCap and its top executives for fraud in 2009, bringing the scheme to a crashing halt. About half of the money raised was never returned to investors. According to court filings, Medical Capital collected close to $325 million in administrative fees from investors. Former Medical Capital president Joseph J. Lampariello last May pleaded guilty to wire fraud and faces up to 21 years in federal prison and an order to pay $49 million in restitution. He has not yet been sentenced. Many of the broker-dealers that sold the MedCap notes have since gone out of business, crushed by the overwhelming costs of legal fees and arbitration losses to clients. The Medical Capital receiver, Thomas Seaman, last month said that he had so far collected $160 million through assets sales, loan payments and other streams of revenue. The latest receiver's report does not include the Bank of New York or Wells Fargo settlements. Wells Fargo “vigorously denies all allegations of wrongdoing, fault liability and damage of any kind to the plaintiffs,” according to the court filing announcing the settlements, which was filed in U.S. District Court for the Central District of California, Southern Division. “This case is really about a fraud committed by Medical Capital, which unfortunately caused a number of parties to suffer losses,” spokeswoman Jen Hibbard said. “We are pleased to be able to put this matter behind us.”

Latest News

BlackRock expands Aladdin's private markets benchmarking tools
BlackRock expands Aladdin's private markets benchmarking tools

New Preqin-powered benchmarks add transparency to private equity and credit performance across BlackRock's platforms.

Fed's Bowman pushes for lighter-touch AI oversight at smaller firms
Fed's Bowman pushes for lighter-touch AI oversight at smaller firms

Supervision vice chair speaks following recent launch of AI adoption practices by regulators.

Why fixed income still belongs in your clients' portfolios
Why fixed income still belongs in your clients' portfolios

In an era of AI euphoria and market FOMO, getting back to basics with fixed income may be the most contrarian and most important move advisors can make.

Voya expands advisor managed accounts to add private market assets
Voya expands advisor managed accounts to add private market assets

Voya Financial adds private equity, credit and real estate options to its AMA program, building on support for looser federal investment rules in retirement accounts.

With executives leaving, Osaic’s Reid now in the spotlight
With executives leaving, Osaic’s Reid now in the spotlight

Shannon Reid, president of Osaic and the network’s number two executive, has plenty of challenges, industry executives said.

SPONSORED Who builds the income when the pension disappears?

Dan Biagini of American Equity says the steady decline of pensions, longer lifespans and a reset in interest rates are rewriting how advisors build retirement income

SPONSORED Why direct indexing stopped being optional

Direct indexing is on pace to outgrow ETFs and mutual funds. Northern Trust's Ken Lassner explains why the advisors who get it wish they had started sooner.